Zura Bio Limited

NASDAQ: ZURA · Healthcare · Biotechnology

PublicHQ San Diego, CA · San DiegoCIK 0001855644Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 58DQ —GM —SS 42

v0.1 · 35/100 weight · pillars only

↑ Altman-Z, balance-sheet leverage · ↓ listing tenure, Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$68.7M

Employees

Market cap

$336.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$68.7M-$68.7M2025

Operating income-$75.2M-$75.2M2025

Total assets$113.9M$113.9M2025

Liabilities$12.4M$12.4M2025

Equity$101.5M$101.5M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Zura Bio Limited earned -$68.7M in FY2025 net income.

Peers · Healthcare

Lineage Cell Therapeutics, Inc.56C Shattuck Labs, Inc.50D Akebia Therapeutics, Inc.66B Fate Therapeutics, Inc.43D

Neighbors

San Diego →

QUALCOMM Incorporated$44.3B79B+Sempra$12.4B64C Realty Income Corporation$5.7B59C ResMed Inc.$5.1B88A Illumina, Inc.$4.3B84B+DexCom, Inc.$4.7B87A

Key facts

CEOSandeep C. Kulkarni

SectorHealthcare

IndustryBiotechnology

HeadquartersSan Diego, CA

ExchangeNASDAQ: ZURA

Employees30

IPO date2023-03-21

Latest filings

8-K2026-07-01 8-K2026-06-18 8-K2026-05-22 8-K2026-05-07 10-Q2026-05-07 DEF 14A2026-04-30 8-K2026-04-23 10-K2026-03-19

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.